Takeda Files For Approval Of Hib Vaccine TAK-816 In Japan
This article was originally published in PharmAsia News
Executive Summary
Takeda filed for approval of TAK-816 haemophilus influenzae Type B vaccine for the prevention of infection caused by Hib.